Connect with us

Health

Jessye Norman’s Family Sue Over Treatment That Allegedly Left Her Paralysed

Jessye Norman’s family sue over treatment that allegedly left her paralysed

She had a voice described as a “grand mansion of sound”, won four Grammy awards and thrilled audiences in the world’s opera house – but suddenly stopped performing in 2015.

When Jessye Norman died four years later at the age of 74, her family said she had passed away from septic shock and multi-organ failure secondary to complications of a spinal cord injury she had sustained in 2015. The circumstances surrounding the injury and disappearance from public life were never explained.

However, it can be revealed that Norman’s brother is suing two renowned doctors and a leading London private hospital for allegedly leaving her paralysed when she underwent surgery in 2015 to try and cure a longstanding and painful back problem.

James Howard Norman Sr has launched a lawsuit alleging that medical negligence by anaesthetist and pain specialist Dr Adnan Al-Kaisy, consultant spinal surgeon Khai Lam and the London Bridge hospital left his sister unable to move her body below the waist.

The doctors and hospital are disputing his claims.

The singer’s brother alleges that she suffered horrendous damage as a result of undergoing a procedure called epidurolysis, which is used to dissolve scar tissue around nerves in the spine.

His claim, which has been lodged at the high court in London, alleges that a series of mistakes meant “the deceased was effectively paralysed from the waist downwards, she could not walk, she could not stand even in a standing frame and she was wheelchair-bound”.

It continues: “She needed extensive care. She lived out her days in a rented apartment in New York since she could not access her home in Westchester County.”

The document claims that Al-Kaisy performed the epidurolysis despite the “limited evidence of the procedure’s efficacy, and little if any evidence of its safety”, despite the operation being little-used in the UK and the fact that it was not recommended by the National Institute of Health and Care Excellence (Nice) for back pain. It also accuses the doctor of not warning the singer of these weaknesses and not acquiring her informed consent to proceed with the procedure in those circumstances.

Norman’s brother contends that Lam also failed to warn the star about the limitations of the epidurolysis and that the procedure was the wrong treatment for the condition she was suffering from, called spinal stenosis. He claims Lam did not warn his sister “of the significant risk of paralysis arising from the procedure, in particular severe and permanent damage to the nerves involving paralysis and loss of the use of the lower part of the body”.

According to Norman his sister developed sciatica in March 2015 after undergoing surgery in New York the month before. A week later she came to London to fulfil some engagements and, on the advice of one of her doctors in her native United States, had a consultation with Lam at the London Bridge hospital. He noted that standing for a few minutes left her with pain and numbness in her right leg. He tried two treatments – steroid injections and inserting a “distraction device” – but neither relieved her symptoms.

Norman Sr’s claim says that Lam then suggested that the singer undergo epidurolysis, and suggested that Al-Kaisy could perform it. Both undertake private medical treatment and also work at Guy’s and St Thomas’ (GSTT), the leading NHS trust in London. Al-Kaisy performed the procedure at the London Bridge private hospital on 12 May 2015.

Both doctors are leading practitioners in their areas of medical expertise. Lam has regularly had articles published in medical journals and spoken at many medical conferences. The website for the GSTT’s private patient unit says that Al-Kaisy “has an international reputation as a leading expert in pain management”.

The legendary soprano was still in hospital in London after her treatment in 2015 when she first sought advice from law firm Leigh Day about taking legal action, and formally launched proceedings the next year. Her brother took over as the claimant when she died in 2019.

His claim also alleges that HCA, the giant American healthcare firm which owns and runs the London Bridge hospital, was negligent in not ensuring that the epidurolysis Lam and Al-Kaisy had recommended was safe, appropriate and evidence-based.

Olive Lewin, the specialist medical negligence solicitor at Leigh Day who is representing Norman Sr in the action, said: “The injuries Miss Norman sustained made her final years extremely difficult. It is a sad fact that despite wanting to, she was unable to continue engaging in the activities and events she loved most in the last four years of her life.

“Jessye Norman had painful sciatica, and was admitted to the London Bridge hospital for a pain-relieving procedure. She ended up being paralysed within hours of a procedure for which the claimant says there was no informed consent, and the efficacy of the procedure has not been proven.

“A negligence claim is being pursued as a result. This remains an ongoing claim, which is currently being defended.”

None of the defendants in the case responded directly to the claims when approached by the Guardian, but they are contesting the allegations against them and each has filed a defence.

HCA Healthcare UK owns and runs other private hospitals in the capital besides the London Bridge, including the Wellington, Princess Grace and Lister.

A HCA spokesperson said: “In order to ensure the confidentiality of every patient we care for, we would not comment on an inquiry into any individual’s care.”

Browne Jacobson solicitors, who are representing Al-Kaisy, said that patient confidentiality meant that he could not say anything but does deny the claims. His lawyer, Matthew Trinder, added: “I can tell you that all the allegations are strenuously denied and that a full defence has been served.”

Lam did not reply to requests to respond.

Health

Lassa fever affects 21 states cases increase in Nigeria

The Nigeria Centre for Disease Control and Prevention, NCDC, says Lassa fever has claimed 168 lives across 21 states in 2025.

The agency in its situation report for epidemiological week 38, disclosed a total of 4,543 suspected cases, of which 897 were confirmed positive, with a case fatality rate of 18.7 per cent.

It stated that four states, Ondo, Edo, Taraba, and Bauchi, remain the epicentres of the outbreak, accounting for 67 per cent of all confirmed cases. Ondo alone has recorded the highest burden, followed by Edo and Bauchi.

According to the agency, other affected states include Ebonyi, Benue, Kogi, Gombe, Plateau, Kaduna, Nasarawa, Enugu, Delta, Anambra, Rivers, Borno, Oyo, Ogun, the Federal Capital Territory, and Lagos.

The report also highlighted that most of the confirmed cases were among people aged 21 to 40, with both men and women affected.

The NCDC said this age group is the most socially and economically active, making them more exposed to the rodent-borne disease.

Lassa fever is an acute viral haemorrhagic illness transmitted to humans through contact with food or household items contaminated by the urine or faeces of infected rats.

Continue Reading

Health

NAFDAC orders removal of 101 products, warns against sale, use

The National Agency for Food and Drug Administration and Control (NAFDAC) has ordered the withdrawal, suspension and cancellation of 101 products from circulation in Nigeria.

The agency gave the order in a post on its official X handle yesterday, stating that the affected products must no longer be manufactured, imported, exported, distributed, advertised, sold or used in the country.

“This is to inform the general public that the following products are approved for withdrawal, suspension and cancellation by NAFDAC. They are therefore no longer permitted for manufacture, importation, exportation, distribution, advertisement, sale and use within Nigeria,” the statement read.

Related News
NAFDAC orders market removal of 101 products
NAFDAC raises alarm over adulterated palm oil sold by traders
Technological disruption, regulatory changes hindering sustainable healthcare – NAFDAC DG
According to NAFDAC, a product is considered withdrawn when its registration is discontinued at the request of the market authorisation holder, suspended when licensing conditions are no longer met, and cancelled when the agency revokes the registration licence completely.

The list encompasses a wide range of medicines and health products, including antibiotics, diabetes medications, cardiovascular drugs, and insulin injectables.

The agency urged healthcare providers, importers, distributors, retailers and the general public to consult the full list of affected products on its website and ensure strict compliance with the directive

Continue Reading

Health

Ebola Virus: NCDC Declares Index Suspects Negative

The Nigeria Centre for Disease Control and Prevention (NCDC) has declared that there was no case of Ebola in the Federal Capital Territory (FCT), after the index patient suspected of having the virus that causes haemorrhagic fever tested negative for Ebola and Marburg disease.

In a statement on his X handle on Friday, the Centre, however, noted that further tests for other VHFs like Lassa and Dengue are ongoing.

“Thanks to early reporting by a traveller and the swift action of vigilant health workers, the risk to the public was minimised.”

It advised the public to seek medical help immediately if they felt unwell, especially after travelling.

The NCDC also advised the public to shun rumours.

“If you feel unwell, especially after travel, seek medical care immediately. Wash hands regularly & practise good hygiene. Avoid contact with anyone showing unexplained fever, bleeding, vomiting, or diarrhoea.

“Rely only on official NCDC updates. Say no to rumours,” the Centre wrote.

The Centre’s update came after the suspect passengers aboard the Rwanda Air to Abuja were thought to have exhibited Ebola-related symptoms.

Similarly, a statement signed by the Director General of NCDC, Dr. Jide Idris, said: “We wish to inform the public that two recent suspected cases of viral hemorrhagic fever in Abuja both tested negative for Ebola and Marburg viruses.

“We are currently testing samples for other viral hemorrhagic fevers like Lassa Fever and Dengue Fever.
“The most recent case involved a traveller who, after returning to Nigeria from Kigali, responsibly presented himself immediately to a hospital in Abuja when he felt unwell.

“His decision to report early, combined with the vigilance of the attending clinician and hospital team, ensured that our public health system was promptly activated and that the risk to the public was minimised.

“This responsible action is highly commendable and a good practice all Nigerians are urged to emulate; when you feel unwell, especially after travel, seek care early. Doing so protects you, your family, and your community.”

Continue Reading
Advertisement

Trending